We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
TIRX | Tian Ruixiang Holdings Ltd | 0.75 | 0.26525 | 54.72% | 3,106,078 |
TRVN | Trevena Inc | 0.572 | 0.17 | 42.29% | 2,470,656 |
ALRN | Aileron Therapeutics Inc | 4.99 | 0.74 | 17.41% | 4,569 |
WKSP | Worksport Ltd | 0.4399 | 0.0646 | 17.21% | 7,315 |
GROM | Grom Social Enterprises Inc | 0.7299 | 0.0968 | 15.29% | 2,750 |
IZM | ICZOOM Group Inc | 6.78 | 0.79 | 13.19% | 338,656 |
CNTB | Connect Biopharma Holdings Inc | 1.75 | 0.20 | 12.90% | 383 |
SINT | SiNtx Technologies Inc | 0.04205 | 0.00475 | 12.73% | 13,895,624 |
POAI | Predictive Oncology Inc | 1.45 | 0.1513 | 11.65% | 246 |
GRTX | Galera Therapeutics Inc | 0.221 | 0.0226 | 11.39% | 474,654 |
ESGL | ESGL Holdings Ltd | 0.523 | 0.0509 | 10.78% | 1,050,995 |
The U.S. Orphan Drug Act is intended to assist and encourage companies to develop safe and effective therapies for the treatment of rare diseases and disorders, defined as one that affects fewer than 200,000 people in the U.S. In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, including government grants for conducting clinical trials, waiver of expensive FDA user fees for the potential submission of a Biologics License Application (BLA), and certain tax credits.
HONG KONG, April 17, 2024 /PRNewswire/ -- ICZOOM Group Inc. (Nasdaq: IZM) (the "Company" or "ICZOOM"), announced today that it voluntarily requested a withdrawal of a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (File No.333-275708, the "Registration Statement") and accordingly cancelled the proposed public offering pursuant to the Registration Statement .
Data presentation at highly influential American Society of Breast Surgeons ("ASBrS") Annual Meeting by Dr. Richard Fine wins Scientific Impact Award as voted by breast surgeons President-Elect of the ASBrS, Dr. Michael Berry, presents data and states "cryoablation is ready for prime time" Company seeks indication for treating women with early stage T1 invasive breast cancer with adjuvant hormone therapy Available reimbursement code for facility expense expected to enhance usage upon receiving marketing authorizationMinimally-invasive ProSense® cryoablation offers highly favorable healthcare economics CAESAREA, Israel, April 15, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive ...
AIRPORT CITY, Israel, April 15, 2024 /PRNewswire/ -- MySize, Inc. (NASDAQ:Â MYSZ) ("MySize" or the "Company"), an omnichannel e-commerce platform and provider of AI-driven measurement solutions to drive revenue growth and reduce costs for its business clients, announced that its Board of Directors has approved a one-for-eight reverse stock split of its common stock that is scheduled to become effective after trading closes on April 19, 2024. Beginning on April 23, 2024, the Company's common stock will trade on the Nasdaq Capital Market on a split adjusted basis under a new CUSIP number 62844N 406. The Company's common stock will continue ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 61,447.50 | -2,404.33 | -3.77% | 1.19T | 7,150,920,844 |
ETH | Ethereum | 3,000.09 | -84.73 | -2.75% | 357.3B | 3,060,912,000 |
USDT | Tether USD | 0.9999 | -0.0001 | -0.01% | 97.84B | 443,173,026 |
BNB | Binance Coin | 537.44 | -0.700784 | -0.13% | 84.48B | 467,946,618 |
SOL | Solana | 135.16 | -1.25 | -0.92% | 58.87B | 2,142,431,839 |
STETH | stETH | 2,994.72 | -69.55 | -2.27% | 29.1B | 16,345,765 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 1,227,656,387 |
XRP | Ripple | 0.4944 | -0.0023 | -0.46% | 26.78B | 444,042,553 |
TONCOIN | Wrapped TON Coin | 6.12 | -0.234492 | -3.69% | 21.02B | 224,211,449 |
DOGE | Dogecoin | 0.14858 | -0.00747 | -4.79% | 21.02B | 639,490,361 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions